Equity

Treasury Stock

CVS Health Treasury Stock increased by 0.0% to $36.79B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 0.1%, from $36.82B to $36.79B. Over 3 years (FY 2022 to FY 2025), Treasury Stock shows an upward trend with a 4.9% CAGR.

Analysis

StatementBalance Sheet Statement
SectionEquity
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ4 2014
Last reportedQ4 2025

How to read this metric

An increase indicates active share buybacks, which can signal management's confidence in the stock or an effort to return capital to shareholders.

Detailed definition

Treasury stock represents the cost of shares that a company has repurchased from the open market and holds in its own tr...

Peer comparison

Standard across all public companies; peers in the pharmaceutical sector often use buybacks to manage earnings per share.

Metric ID: treasury_stock

Historical Data

12 periods
 Q4 '22Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25
Value$31.86B$33.93B$33.83B$33.84B$36.77B$36.92B$36.81B$36.82B$36.74B$36.85B$36.78B$36.79B
QoQ Change+6.5%-0.3%+0.0%+8.7%+0.4%-0.3%+0.0%-0.2%+0.3%-0.2%+0.0%
YoY Change+6.2%+8.8%+8.8%+8.8%-0.1%-0.2%-0.1%-0.1%
Range$31.86B$36.92B
CAGR+5.4%
Avg YoY Growth+4.0%
Median YoY Growth+3.1%

Frequently Asked Questions

What is CVS Health's treasury stock?
CVS Health (CVS) reported treasury stock of $36.79B in Q4 2025.
How has CVS Health's treasury stock changed year-over-year?
CVS Health's treasury stock decreased by 0.1% year-over-year, from $36.82B to $36.79B.
What is the long-term trend for CVS Health's treasury stock?
Over 3 years (2022 to 2025), CVS Health's treasury stock has grown at a 4.9% compound annual growth rate (CAGR), from $31.86B to $36.79B.
What does treasury stock mean?
The value of shares a company has bought back from the market.